Get in touch today 206.598.4100 or

Schedule an Appointment

Tyler Gutschenritter, MD

Education and Training

College: University of Tulsa, Tulsa, OK; Biochemistry 2014

Medical Education: University of Oklahoma, Oklahoma City, OK 2018

Published works

Ludmir EB, Gutschenritter T, Pinnix CC, Gunther JR, Nastoupil LJ, Khoury JD, Medeiros LJ Dabaja BS, Milgrom SA. Coincident Primary Breast Lymphoma and Gastrointestinal Stromal Tumor: Case Series and Molecular Mechanisms. Onco Targets Ther. 2018. Dec 10;11:8937-8942

Gutschenritter T, Machiorlatti M, Vesely S, Ahmad B, Razaq W, Razaq M. Outcomes and prognostic factors of resected salivary gland malignancies: Examining a single institution’s 12-year experience. Anticancer Res. 2017 Sep;37(9):5019-5025.

Gutschenritter T, Matthiesen C, Razaq M. Protracted Lhermitte sign following cisplatin and intensity modulated radiation therapy for nasopharyngeal carcinoma. American Journal of Therapeutics. 2017 Feb 17.

Gutschenritter T, Zhao L, Matthiesen C, Razaq W, Razaq M. Concurrent colon adenocarcinoma and hepatoid lung adenocarcinoma with normal serum level and negative immunostain of alpha-fetoprotein. Clinical Case Reports and Reviews. 2016, 2(3): 366-368.

Bedford, R.; LePage, D.; Hoffmann, R.; Kennedy, S.; Gutschenritter, T.; Bull, L.; Sujijantarat, N.; DiCesare, J.C.; Sheaff, R.J. Luciferase Inhibition by a Novel Naphthoquinone. J. Photochem. Photobiol. B [Online] 2012, 107, pp.55-64.